Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

“Individuals that experience long COVID report a constellation of symptoms, and these symptoms can be cognitive, they can be ...

University of Virginia researchers uncover immune system changes linked to lung damage in Long COVID patients, offering hope for personalized treatments to address lingering respiratory complications.

Identifying long COVID sufferers through the identified biomarkers could help the medical community develop multidisciplinary treatment for their symptoms, he said. “I think patients and our ...

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

Long COVID patients come to his practice complaining ... then we can develop multidisciplinary treatment to focus on all aspects of the individual," he added. "I think patients and our medical ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...